Menu

RIKEN Head Leaving Early

Ryoji Noyori is stepping down from his post as the leader of the premier Japanese research institute before his tenure expires.

Mar 10, 2015
Kerry Grens

WIKIMEDIA, ??????????:BRUNEIThe president of the RIKEN research institute in Japan, Ryoji Noyori, will resign this month, according to news reports. He was slated to hold the position for another three years.

According to Asahi Shimbun, Noyori cited his age and his many years already spent serving as RIKEN’s president as part of his decision to leave. Noyori also recently weathered considerable turmoil at RIKEN over scientific misconduct regarding a stem cell technique and the suicide of an involved investigator. However, education “[m]inistry officials said that he is not resigning to take responsibility for the recent scandal,” Asahi Shimbun reported.

The 76-year-old Nobel laureate has led RIKEN for more than a decade. The Ministry is searching for his replacement.

Hat tip: ScienceInsider

Correction (March 12): The first sentence originally stated that Ryoji Noyori said he will resign; rather, education ministry officials made the announcement. The RIKEN press office has not received confirmation of his resignation. The Scientist regrets the error.

Update (March 24): Nature reported today that Noyori has resigned. His successor will be physicist Hiroshi Matsumoto.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.